Urokinase-type plasminogen activator receptor

The use of substances capable of preventing the binding of a receptor binding form of u-PA to a u-PA receptor (u-PAR) in a mammal and thereby preventing u-PA from converting plasminogen into plasmin thereby preventing cell surface plasminogen activation which is believed to play an important role in...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: W. D. SCHLEUNING, ROSS W. STEPHENS, KELD DANO, HANNELE TAPIOVAARA, FRANCESCO BLASI, PETER KRISTENSEN, JARI POLLANEN, ANTII VAHERI, LISBETH BIRK MOLLER, MICHAEL PLOUG, MARIA TERESA MASUCCI, EBBE RONNE, VINCENT ELLIS, MARIA VITTORIA CUBELLIS, ANN LOURING ROLDAN, ETTORE APPELLA, LEIF ROGE LUND, EEVA-MARJATTA SALONEN, NIELS BEHRENDT, LASZLO PATTHY, CHARLES PYKE
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The use of substances capable of preventing the binding of a receptor binding form of u-PA to a u-PA receptor (u-PAR) in a mammal and thereby preventing u-PA from converting plasminogen into plasmin thereby preventing cell surface plasminogen activation which is believed to play an important role in tissue remodelling, particularly during cancer invasion for preparing a composition for preventing or counteracting localized proteolytic activity in a mammal, in particular a human.